The layperson's guide to antibiotics. What they are, how they work, when they will not work, Extended information and links.
Monday, January 07, 2013
Antibiotic resistance pattern among common bacterial uropathogens with a special reference to ciprofloxacin resistant Escherichia coli.
Thursday, December 27, 2012
Antibiotics' effect on chest infections queried
Friday, November 16, 2012
Scientists Discover New Way for Antibiotic Resistance to Spread
Scientists Discover New Way for Antibiotic Resistance to Spread
Tuesday, November 06, 2012
Antibiotic Resistance Killing Off Bees
Friday, November 02, 2012
Vancomycin-resistant enterococci (VRE) : Recent results and trends in development of antibiotic resistance.
Vancomycin-resistant enterococci (VRE) : Recent results and trends in development of antibiotic resistance.
Source
Abstract
Friday, October 19, 2012
Antibiotics for clinically diagnosed acute rhinosinusitis in adults.
Antibiotics for clinically diagnosed acute rhinosinusitis in adults.
Source
Abstract
BACKGROUND:
OBJECTIVES:
SEARCH METHODS:
SELECTION CRITERIA:
DATA COLLECTION AND ANALYSIS:
MAIN RESULTS:
AUTHORS' CONCLUSIONS:
Friday, September 28, 2012
European Antibiotic Awareness Day 2012: general practitioners encouraged to TARGET antibioticsthrough guidance, education and tools.
European Antibiotic Awareness Day 2012: general practitioners encouraged to TARGET antibiotics through guidance, education and tools.
Source
Abstract
Saturday, September 01, 2012
Nano-technology for targeted drug delivery to combat antibiotic resistance.
Nano-technology for targeted drug delivery to combat antibiotic resistance.
Source
Abstract
Alliance against MDRO: Safeguarding antibiotics.
Alliance against MDRO: Safeguarding antibiotics.
Source
Abstract
- Alliance;
- Antibiotics;
- Resistance to antibiotics;
- Hygiene;
- Antibiotic stewardship
Sunday, August 12, 2012
A situational analysis of antimicrobial drug resistance in Africa: are we losing the battle?
A situational analysis of antimicrobial drug resistance in Africa: are we losing the battle?
Source
Abstract
BACKGROUND:
METHODS:
RESULTS:
CONCLUSION:
Selection of resistance at lethal and non-lethal antibiotic concentrations.
Selection of resistance at lethal and non-lethal antibiotic concentrations.
Aug 2012
Hughes D, Andersson DI.
Source
Abstract
Monday, September 28, 2009
Assessment of antibiotic resistance in probiotic strain Lactobacillus brevis KB290.
Probiotics Research Department, Research Institute, Kagome Company, Limited, 17 Nishitomiyama, Nasushiobara, Tochigi, 329-2762, Japan. Masanori_Fukao@kagome.co.jp
Our purpose was to investigate the safety of the probiotic strain Lactobacillus brevis KB290. The European Qualified Presumption of Safety (QPS) evaluation approach was applied to the strain. We determined the strain's antibiotic resistance, verified it at the genetic level, and determined whether it could be transferred to intestinal microflora. Of 14 antibiotics tested, 11 showed MICs within the limits of the QPS criteria. However, the L. brevis KB290 MICs of ciprofloxacin (a fluoroquinolone), tetracycline, and vancomycin were two, four, and eight times, respectively, the breakpoint MICs suggested by the European Scientific Committee on Animal Nutrition, and the MIC of tetracycline was eight times the breakpoint MIC suggested by the European Scientific Panel on Additives and Products or Substances Used in Animal Feed. Using analysis of gapped-genome sequences, we found no known transferable determinants for tetracycline or vancomycin resistance, and we found no mutations in the quinolone resistance-determining regions of the genes encoding GyrA or ParC for ciprofloxacin resistance associated with insertion sequences, integrons, or transposons. These data were confirmed by using PCR primers specific for the respective genes. We assessed the transferability of the resistance traits in conjugation experiments with enterococci and obtained no transconjugants, strongly suggesting that the resistance traits were not transferable. This study demonstrated that the antibiotic resistance observed in L. brevis KB290 was due not to dedicated mechanisms but to intrinsic resistance. According to the QPS criteria, these results provide safety assurance for the ongoing use of L. brevis KB290 as a probiotic.
PMID: 19777895 [PubMed - in process]
Sunday, September 20, 2009
Rational antibiotic use.
Rational antibiotic use.J Infect Dev Ctries. 2009 Mar
Tunger O, Karakaya Y, Cetin CB, Dinc G, Borand H.
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey. otunger@hotmail.com
BACKGROUND: Development of resistance to antimicrobial agents and increase of cost as the result of unnecessary and inappropriate use of antibiotics has become a global health problem. Therefore many strategies, which are aimed at optimizing antibiotic therapy, have been developed until now. In Turkey, an antibiotic restriction policy as a governmental solution was applied to decrease the antibiotic use and especially costs by Ministry of Health in 2003. The aim of this study is to evaluate the rational antibiotic use and the impact of the implementation of new restriction policy, with their reinforcement by infectious disease specialist, on the hospital wide use of antibiotics.
METHODOLOGY: The data of the inpatients received antibiotics (n=495) during January-June 2006 were compared with our previous study performed by the same methodology before the restriction policy in 1998. In both studies, prospective active daily surveillance of patients was performed by three infectious disease specialists. The appropriateness of antibiotic therapy was determined using the criteria described by Kunin and Jones. The data were analyzed by using SPSS for Windows.
RESULTS: Thirty-seven patients were treated for burn cellulitis, 26 (70%) of whom were treated initially with continuous-infusion oxacillin. Other initial antibiotics were chosen because of concomitant infections, penicillin allergy, or development of cellulitis during treatment with a beta-lactam antibiotic. Oxacillin treatment was successful in 19 patients (73%). Success required an average of 5.16 days, with 1.53 days required for fever resolution and 0.89 days for resolution of leukocytosis. Seven patients who did not respond rapidly were switched to intravenous vancomycin an average of 2.4 days after starting oxacillin, leading to a 100% success rate. There were no deaths, and only one suspected case of allergic reaction to oxacillin. In eleven patients treated with other antibiotics, the success rate was 75%. Success with these drugs required a longer treatment course of 6.45 days. Leukocytosis resolved significantly more slowly at 4.45 days -p equals 0.02-, and fever resolution was also slower at 3.18 days.
CONCLUSIONS: Continuous-infusion oxacillin was successful in the treatment of 73% of patients, a success rate that might have been higher with clinical patience, and leukocytosis resolved faster than with other antibiotics. Failure of continuous-infusion oxacillin can be managed without clinical consequence by conversion to intravenous vancomycin.
PubMed
Tuesday, February 27, 2007
Pre- and probiotics
Ther Umsch. 2007 Mar
Meier R,
Lochs H.
Medizinische Universitatsklinik, Abteilung fur Gastroenterologie, Hepatologie und Ernahrung, Kantonsspital, Liestal.
Nowadays, the regular consumption of pre- and probiotics is recommended to provide various positive health benefits. The in vitro and in vivo demonstrated actions on the intestinal microflora, the mucosal barrier and the immunological system are very interesting to propose beneficial health effects, but the scientific proof in humans is not demonstrated yet. Pre- and probiotics are very active in the intestinal tract (mainly in the colon) by maintaining a healthy gut microflora and influencing metabolic, trophic and protective mechanism.
Prebiotics stimulates the growth of apathogen bacteria and increase the short chain fatty acid concentration by fermentation. Short chain fatty acids are necessary substrates for a healthy gut. Probiotics inhibit the growth of pathogen bacteria, reduce the translocation of bacteria and toxins and modulate the intestinal immune system. For some specific clinical diseases (ulcerative colitis, pouchitis, diarrhoea) a therapeutic and prophylactic effect with pre- and probiotics was shown.
In the near future more indications for pre- and probiotics (used as a single strain or as in a combination) will be added. Promising results are already shown in irritable bowel syndrome, prevention of antibiotic induced diarrhoea, in surgical and in intensive care patients.
Future studies should focus to determine the characteristics of a healthy gut and the evaluation of specific health benefits by well-designed, controlled human studies of adequate duration.
PMID: 17323288 [PubMed - in process]
Tuesday, February 20, 2007
Strategies in the treatment of infections with antibiotics in intensive care medicine.
Strategies in the treatment of infections with antibiotics in intensive care medicine.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2007 Feb
Deja M,
Nachtigall I,
Halle E,
Kastrup M,
Guill MM,
Spies CD.
Abstract
The treatment of infections is one of the central elements in post-operative intensive care and contributes significantly to outcome. Measures of quality of antibiotic therapy include survival, duration of ICU or in-atient stay and rates of organ failure, antibiotic resistance or nosocomial infection. The pre-requisites for antibiotic prescribing in the intensive care unit are as follows: the treatment has to be started early, the antibiotic must be effective against probable causative organisms, the patient's risk factors for infection with multi-drug resistant organisms must be taken into account, local patterns of resistance must be known, an effective dosage must be used and the duration of therapy should be adjusted to the patient's risk factors and probable causative organisms. The multiplicity of factors which must be taken into account when determining timely empirical therapy and the fact that this must be possible at any time of the day, make local standard operating procedures for antibiotic prescribing imperative. These standards should reflect local resistance patterns and should be regularly reviewed. The aim of this educational article is to portray a selection of the pre-requisites and strategies available in the treatment of infections with antibiotics in intensive care medicine.
PMID: 17309018 [PubMed - as supplied by publisher]